The Relations Between HSG Proven Tubal Occlusion, Stimulated Intrauterine Insemination and Pregnancy Rate

Tubal factor infertility is one of the main causes of female infertility. Although its sensitivity is low, hysterosalpingography (HSG) is remains the first-line method for evaluating tubal patency. To compare pregnancy rates in patients with HSG proven proximal or distal unilateral tubal occlusion,...

Full description

Saved in:
Bibliographic Details
Published inBalkan medical journal Vol. 34; no. 1; pp. 60 - 63
Main Authors Yetkin Yıldırım, Gonca, Orta Korkut, Ahu, Köroğlu, Nadiye, Susan Türkgeldi, Lale
Format Journal Article
LanguageEnglish
Published Turkey Trakya Üniversitesi 01.01.2017
Galenos Publishing
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Tubal factor infertility is one of the main causes of female infertility. Although its sensitivity is low, hysterosalpingography (HSG) is remains the first-line method for evaluating tubal patency. To compare pregnancy rates in patients with HSG proven proximal or distal unilateral tubal occlusion, and unexplained infertility undergoing both controlled ovarian stimulation (COS) and intrauterine insemination (IUI). Case control study. In total, 237 patients undergoing ovulation induction (OI) with gonadotropins and IUI were divided into two groups and evaluated. Study group consisted 59 patients with HSG proven unilateral tubal pathology, and 178 patients with unexplained infertility taken as control subjects. Cumulative pregnancy rate was the primary endpoint. Cumulative pregnancy rates after three cycles of OI and IUI were 15.25% in study group and 20.79% in control group. Pregnancy rates between two groups were not statistically significant. Although, pregnancy rates in patients with proximal tubal occlusion (21.8%) were higher than in those with distal tubal occlusion (7.4%), the difference was not statistically significant. Our study data shows that, regardless of the HCG proven occlusion area, COS and IUI might be a preferred treatment modality in patient with unilateral tubal occlusion.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2146-3123
2146-3131
DOI:10.4274/balkanmedj.2016.0289